Financials
Financial year 2025
Melfin Medical Consulting from Hoegaarden, company number BE0645705145, closed financial year 2025 with a result of € -22,231 after tax. For that financial year Melfin Medical Consulting recorded a gross margin of € 105,141 and equity of € 322,911. Compared with financial year 2024, the result moved from € 65,865 to € -22,231. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on March 31, 2026.
€ 322,911
▼ 6% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -22,231
▼ still € 65,865 profit in 2024
Profit after tax over the fiscal year.
€ 6,923
▼ 68% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 304,361.
People and assets in 2025
€ 58,232
▼ 24% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 804,808
▼ 6% vs 2024
€ 60,725 is repaid this year. At this pace the long-term loan is gone in ≈ 13 years.
€ 8,166
▲ 17% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 24,803
▲ 65% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 255,721 | € 235,344 | € 201,425 | € 105,141 | ▼ 48% |
| Profit after taxes | € 106,493 | € 88,509 | € 65,865 | € -22,231 | ▼ € 88,096 |
| Equity | € 340,769 | € 344,277 | € 345,142 | € 322,911 | ▼ 6% |
| Total debts | € 1,002,120 | € 950,366 | € 938,930 | € 837,777 | ▼ 11% |
| Cash | € 87,250 | € 80,155 | € 21,436 | € 6,923 | ▼ 68% |
| Land & buildings | € 1,128,801 | € 1,066,742 | € 1,029,692 | € 971,815 | ▼ 6% |
| Retained profit | € 322,219 | € 325,727 | € 326,592 | € 304,361 | ▼ 7% |
| Dividend | € 50,000 | € 85,000 | € 65,000 | € 0 | ▼ 100% |
| Bank debt | € 883,258 | € 844,674 | € 851,866 | € 804,808 | ▼ 6% |
| Balance sheet total | € 1,342,889 | € 1,294,644 | € 1,284,072 | € 1,160,688 | ▼ 10% |
Key figures of Melfin Medical Consulting, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to Melfin Medical Consulting?
What happened at Melfin Medical Consulting in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 22,231 (▼ € 88,096 vs 2024). Source: NBB ↗
- Gijs Klarenbeek became a director. NBB
- Carine Sumbula became a director. NBB
- New establishment in Hoegaarden. KBO
- Start of the company according to the CBE. KBO
In short
From € 106,493 profit in 2022 to € 22,231 loss in 2025.
Paid € 94,774 in corporate taxes since 2022.
Best year ever: 2022, with € 106,493 profit.
Paid out € 200,000 in dividends to the owners in total.
A new publication or filing at Melfin Medical Consulting? We notify you, reason included.
Follow Melfin Medical ConsultingDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Melfin Medical Consulting are Gijs Klarenbeek and Carine Sumbula.
Directors
According to the 2025 annual accounts
Gijs Klarenbeek
Director
since 2023
Carine Sumbula
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Boterstraat 26
3321 Hoegaarden
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0645.705.145
- VAT number
- BE 0645.705.145
- Registered office
- Boterstraat 26, 3321 Hoegaarden
- Names & denominations
- Melfin Medical Consulting · MMed
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 January 2016
- Peppol
- Active · Active since 30 Dec 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Organisatie van congressen en beurzen
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige zakelijke dienstverlening, neg
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
+1